Modulation of ATP-induced calcium signaling by progesterone in T47D-Y breast cancer cells

Molecular and Cellular Endocrinology

Volumn 319, Issue 1-2, 2010, Pages 109-115

  Lee, Karen L ^a   Dai, Qunsheng ^a   Hansen, Elizabeth L ^a   Saner, Carrie N ^a   Price, Thomas M ^a  

^a DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

ATP; Progesterone; Purinergic; T47D Y breast cancer cells

Indexed keywords

ADENOSINE TRIPHOSPHATE; GESTAGEN; MITOGEN ACTIVATED PROTEIN KINASE; PROGESTERONE; PROGESTERONE RECEPTOR; PURINERGIC P2 RECEPTOR;

ARTICLE; BREAST CANCER; CALCIUM MOBILIZATION; CALCIUM SIGNALING; CALCIUM TRANSPORT; CANCER CELL; CELL FRACTIONATION; CELL MEMBRANE; CELL MEMBRANE PERMEABILITY; CONTROLLED STUDY; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; HORMONE RESPONSIVE ELEMENT; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; WESTERN BLOTTING;

ADENOSINE TRIPHOSPHATE; BLOTTING, WESTERN; CALCIUM; CALCIUM SIGNALING; CELL FRACTIONATION; CELL LINE, TUMOR; CELL NUCLEUS; CELLS, CULTURED; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG INTERACTIONS; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; HUMANS; MAP KINASE SIGNALING SYSTEM; PHOSPHORYLATION; PROGESTERONE; PROGESTINS; RECEPTORS, PROGESTERONE; RECEPTORS, PURINERGIC P2;

EID: 77249117167     PISSN: 03037207     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mce.2010.01.004     Document Type: Article

References (28)

1. Abbracchio M.P., Burnstock G., Boeynaems J.-M., Barnard E.A., Boyer J.L., Kennedy C., Knight G.E., Fumagalli M., Gachet C., Jacobson K.A., and Weisman G.A. International Union of Pharmacology LVIII: update on the P2Y G protein-coupled nucleotide receptors: from molecular mechanisms and pathophysiology to therapy. Pharmacol. Rev. 58 (2006) 281-341
2. Bird G.S.J., and Putney Jr. J.W. Capacitative calcium entry supports calcium oscillations in human embryonic kidney cells. J. Physiol. 562 (2005) 697-706
3. Blackmore P., Neulenn J., Lattanzio F., and Beebeq S. Cell surface-binding sites for progesterone mediate calcium uptake in human sperm. J. Biol. Chem. 266 (1991) 18655-18659
4. 2 purinoceptors: from molecular biology to functional responses. Trends Pharmacol. Sci. 16 (1995) 133-139
5. Boonyaratanakornkit V., and Edwards D. Receptor mechanisms mediating non-genomic actions of sex steroids. Semin. Reprod. Med. 25 (2007) 139-153
6. 2+ mobilization is strongly potentiated by a parathyroid/cAMP-dependent protein kinase pathway independently of mitogen-activated protein kinase. J. Biol. Chem. 274 (1999) 14315-14324
7. Burnstock G. Purinergic signaling and vascular cell proliferation and death. Arterioscler. Thromb. Vasc. Biol. 22 (2002) 364-373
8. Dixon C., Bowler W., Fleetwood P., Ginty A., Gallagher J., and Carron J. Extracellular nucleotides stimulate proliferation in MCF-7 breast cancer cells via P2-purinoceptors. Br. J. Cancer 75 (1997) 34-39
9. Fu X.-D., Giretti M., Goglia L., Flamini M., Sanchez A., Baldacci C., Garibaldi S., Sitruk-Ware R., Genazzani A., and Simoncini T. Comparative actions of progesterone, medroxyprogesterone acetate, drospirenone and nestorone on breast cancer cell migration and invasion. BMC Cancer 8 (2008) 166
10. Levin E. Cellular functions of plasma membrane estrogen receptors. Steroids 67 (2002) 471-475
11. Lippert C., Seeger H., Wallwiener D., and Mueck A. The effect of medroxyprogesterone acetate and norethisterone on the estradiol stimulated proliferation in MCF-7 cells: comparison of continuous combined versus sequential combined estradiol/progestin treatment. Eur. J. Gynaecol. Oncol. 22 (2001) 331-335
12. Luconi M., Francavilla F., Porazzi I., Macerola B., Forti G., and Baldi E. Human spermatozoa as a model for studying membrane receptors mediating rapid nongenomic effects of progesterone and estrogens. Steroids 69 (2004) 553-559
13. Pandolfi C., Macerola B., Zugaro A., Santucci R., Francavilla S., and Francavilla F. Monoclonal antibody c262 counteracts the stimulatory effect of progesterone on sperm-oocyte fusion. Int. J. Androl. 28 (2005) 27-30
14. Parekh A.B., and Putney Jr. J.W. Store-operated calcium channels. Physiol. Rev. 85 (2005) 757-810
15. Pawlak K.J., Zhang G., and Wiebe J.P. Membrane 5α-pregnane-3,20-dione (5αP) receptors in MCF-7 and MCF-10A breast cancer cells are up-regulated by estradiol and 5αP and down-regulated by the progesterone metabolites, 3α-dihydroprogesterone and 20α-dihydroprogesterone, with associated changes in cell proliferation and detachment. J. Steroid Biochem. Mol. Biol. 97 (2005) 278-288
16. Pedram A., Razandi M., Sainson R.C.A., Kim J.K., Hughes C.C., and Levin E.R. A conserved mechanism for steroid receptor translocation to the plasma membrane. J. Biol. Chem. 282 (2007) 22278-22288
17. Price T.M., Hansen E.L., and Oliver T.N. Immunofluorescent localization of a novel progesterone receptor(s) in a T47D-Y breast cancer cell line lacking genomic progesterone receptor expression. J. Soc. Gynecol. Invest. 12 (2005) 610-616
18. Ralevic V., and Burnstock G. Receptors for purines and pyrimidines. Pharmacol. Rev. 50 (1998) 413-492
19. Razandi M., Pedram A., Greene G.L., and Levin E.R. Cell membrane and nuclear estrogen receptors (ERs) originate from a single transcript: studies of ERα and ERβ expressed in Chinese hamster ovary cells. Mol. Endocrinol. 13 (1999) 307-319
20. Rossi A., Picotto G., De Boland A., and Rl B. Evidence on the operation of ATP-induced capacitative calcium entry in breast cancer cells and its blockade by 17β-estradiol. J. Cell Biochem. 87 (2002) 324-333
21. Saner K., Welter B., Zhang F., Hansen E., Dupont B., Wei Y., and Price T. Cloning and expression of a novel, truncated progesterone receptor. Mol. Cell. Endocrinol. 200 (2003) 155-163
22. Sartorius C., Groshong S., Miller L., Powell R., Tung L., Takimoto G., and Horwitz K. New T47D breast cancer cell lines for the independent study of progesterone B- and A-receptors: only antiprogestin-occupied B-receptors are switched to transcriptional agonists by cAMP. Cancer Res. 54 (1994) 3868-3877
23. Sartorius C., Shen T., and Horwitz K.B. Progesterone receptors A and B differentially affect the growth of estrogen-dependent human breast tumor xenografts. Breast Cancer Res. Treat. 79 (2003) 287-299
24. Sathya G., Jansen M., Nagel S., Cook C., and Mcdonnell D. Identification and characterization of novel estrogen receptor-β-sparing antiprogestins. Endocrinology 143 (2002) 3071-3082
25. i elevation can substitute for receptor activation. J. Biol. Chem. 273 (1998) 23110-23117
26. Wagstaff S.C., Bowler W.B., Gallagher J.A., and Hipskind R.A. Extracellular ATP activates multiple signaling pathways and potentiates growth factor-induced c-fos gene expression in MCF-7 breast cancer cells. Carcinogenesis 21 (2000) 2175-2181
27. Watson C., Norfleet A., Pappas T., and Gametchu B. Rapid action of estrogens in GH3/B6 pituitary tumor cells via a plasma membrane version of estrogen receptor-α. Steroids 64 (1999) 5-13
28. Zhu Y., Bond J., and Thomas P. Identification, classification, and partial characterization of genes in humans and other vertebrates homologous to a fish membrane progestin receptor. PNAS 100 (2003) 2237-2242